ECO 2026: Update on Nutritional Considerations for Incretin-Based Therapies in Obesity Management
EASO/EFAD Position Statement on Nutritional Considerations for Incretin-Based Therapies in Obesity Management
Presenter :Tolvanen, L
A consensus statement by European Association for the Study of Obesity (EASO) and European Federation of the Associations of Dietitians (EFAD) evaluated nutritional considerations during incretin-based therapies, focusing on Medical Nutrition Therapy (MNT) by Registered Dietitians (RDs).
Reduced appetite and early satiety lower energy intake but increase risk of inadequate protein intake, micronutrient deficiencies, and dehydration. MNT supports dietary quality, symptom management (nausea, constipation, diarrhoea), and development of regular eating patterns and mindful eating. It also addresses food insecurity, weight-loss expectations, plateaus, and preparation for treatment discontinuation. Multidisciplinary monitoring improves safety and effectiveness.
Individualised MNT is integral to obesity pharmacotherapy, helping prevent nutritional deficiencies, mitigate gastrointestinal adverse events, preserve lean mass, and support sustainable long-term weight management.
33rd European Congress on Obesity (ECO 2026), 12th -15th May 2026, Istanbul, Turkey.


